Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report issued on Wednesday morning. The firm issued a hold rating on the stock.

Retractable Technologies Trading Up 1.0 %

Shares of NYSE RVP opened at $1.05 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 8.18 and a current ratio of 11.02. Retractable Technologies has a 52-week low of $0.87 and a 52-week high of $1.34. The firm has a 50 day moving average price of $1.13 and a two-hundred day moving average price of $1.14. The stock has a market cap of $31.44 million, a P/E ratio of -4.04 and a beta of 2.08.

Retractable Technologies (NYSE:RVPGet Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported $0.01 earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 18.84% and a negative return on equity of 7.55%. The firm had revenue of $7.60 million during the quarter.

Insider Transactions at Retractable Technologies

In other news, CEO Thomas J. Shaw acquired 48,635 shares of the firm’s stock in a transaction dated Thursday, May 16th. The stock was bought at an average cost of $1.03 per share, for a total transaction of $50,094.05. Following the completion of the transaction, the chief executive officer now directly owns 14,417,148 shares in the company, valued at approximately $14,849,662.44. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders bought a total of 178,338 shares of company stock worth $185,418 over the last three months. 55.00% of the stock is owned by company insiders.

About Retractable Technologies

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Further Reading

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.